DK0553294T3 - Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme - Google Patents

Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme

Info

Publication number
DK0553294T3
DK0553294T3 DK92900114T DK92900114T DK0553294T3 DK 0553294 T3 DK0553294 T3 DK 0553294T3 DK 92900114 T DK92900114 T DK 92900114T DK 92900114 T DK92900114 T DK 92900114T DK 0553294 T3 DK0553294 T3 DK 0553294T3
Authority
DK
Denmark
Prior art keywords
treatment
cell proliferation
compositions
preparation
proliferation disorders
Prior art date
Application number
DK92900114T
Other languages
English (en)
Inventor
Lawrence M Blatt
Milton W Taylor
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0553294T3 publication Critical patent/DK0553294T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92900114T 1990-10-17 1991-10-15 Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme DK0553294T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59920690A 1990-10-17 1990-10-17
US77292291A 1991-10-15 1991-10-15
PCT/US1991/007722 WO1992006707A1 (en) 1990-10-17 1991-10-15 Methods and compositions for the treatment of cell proliferation disorders

Publications (1)

Publication Number Publication Date
DK0553294T3 true DK0553294T3 (da) 1999-08-23

Family

ID=27083273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92900114T DK0553294T3 (da) 1990-10-17 1991-10-15 Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme

Country Status (17)

Country Link
EP (1) EP0553294B1 (da)
JP (1) JP3496937B2 (da)
CN (1) CN1053117C (da)
AT (1) ATE174798T1 (da)
AU (1) AU660633B2 (da)
CA (1) CA2094275C (da)
DE (1) DE69130679T2 (da)
DK (1) DK0553294T3 (da)
ES (1) ES2128348T3 (da)
HK (1) HK1010340A1 (da)
IE (1) IE913656A1 (da)
IL (1) IL99778A (da)
NO (1) NO931413D0 (da)
NZ (1) NZ240264A (da)
PT (1) PT99265B (da)
SG (1) SG52537A1 (da)
WO (1) WO1992006707A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
WO1995015177A2 (en) * 1993-12-02 1995-06-08 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
US7232805B2 (en) * 2003-09-10 2007-06-19 Inflabloc Pharmaceuticals, Inc. Cobalamin conjugates for anti-tumor therapy
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
MXPA06013412A (es) 2004-05-19 2007-01-23 Maxygen Inc Polipeptidos de interferon-alfa y conjugados.
MY167668A (en) * 2005-03-09 2018-09-21 Superlab Far East Ltd Uses of recombinant super-compound interferons
JP2008545393A (ja) 2005-05-18 2008-12-18 マキシジェン, インコーポレイテッド 進歩したインターフェロンαポリペプチド

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4879471A (en) * 1987-03-25 1989-11-07 Measurex Corporation Rapid-scanning infrared sensor

Also Published As

Publication number Publication date
NZ240264A (en) 1997-07-27
ATE174798T1 (de) 1999-01-15
NO931413L (no) 1993-04-16
NO931413D0 (no) 1993-04-16
EP0553294A4 (en) 1994-11-23
AU9023591A (en) 1992-05-20
IE913656A1 (en) 1992-04-22
SG52537A1 (en) 1998-09-28
IL99778A0 (en) 1993-02-21
DE69130679T2 (de) 1999-05-06
PT99265B (pt) 1999-04-30
CA2094275C (en) 2003-06-03
CN1064018A (zh) 1992-09-02
DE69130679D1 (de) 1999-02-04
CA2094275A1 (en) 1992-04-18
PT99265A (pt) 1992-08-31
EP0553294B1 (en) 1998-12-23
CN1053117C (zh) 2000-06-07
AU660633B2 (en) 1995-07-06
IL99778A (en) 1996-11-14
WO1992006707A1 (en) 1992-04-30
ES2128348T3 (es) 1999-05-16
JP3496937B2 (ja) 2004-02-16
HK1010340A1 (en) 1999-06-17
JPH06502426A (ja) 1994-03-17
EP0553294A1 (en) 1993-08-04

Similar Documents

Publication Publication Date Title
DK442688A (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
IT1302559B1 (it) Busto ortopedico modulare regolabile per il trattamento dellascoliosi
DK108888A (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmaader til fremstilling af henholdsvis denne tablet og dette granulat
DK0553294T3 (da) Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme
DK333788A (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
FR2657259B1 (da)
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
DE69103824D1 (de) Patientenliegetische.
DK0579765T3 (da) Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari
DK469487A (da) Laegemiddel til behandling af fedme
DK102488D0 (da) Praeparat til behandling af tandsygdomme
IT9019882A1 (it) Composizioni farmaceutiche comprendenti derivati del glicerolo-5- fosfato atte al trattamento di patologie del sistema nervoso
IT9067821A0 (it) Piastra complementare del tavolo chirurgico